Nicholas R. Harrison

Nicholas R. Harrison

Auto-generated profile, based on publicly available information

Nicholas R. Harrison

Duke‐Margolis Center for Health Policy Duke University Durham North Carolina USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Cell Reports
Verified
Journal Article
Open access
THTiffany Hughes
Tiffany Hughes
EBEdward L. Briercheck
Edward L. Briercheck
AFAharon G. Freud
Aharon G. Freud
RTRossana Trotta
Rossana Trotta
SMSusan McClory
Susan McClory
MCMichael A. Caligiuri
Michael A. Caligiuri
Accumulating evidence indicates that human natural killer (NK) cells develop in secondary lymphoid tissue (SLT) through a so-called "stage 3" developmental intermediate minimally characterized by a CD34(-)CD117(+)CD94(-) immunophenotype that lacks mature NK cell function. This stage 3 population is heterogeneous, potentially composed of functionally distinct innate lymphoid cell (ILC) types that include interleukin-1 receptor (IL-1R1)-positive, IL-22-producing ILC3s. Whether human ILC3s are developmentally related to NK cells is a subject of ongoing investigation. Here, we show that antagonism of the aryl hydrocarbon receptor (AHR) or silencing of AHR gene expression promotes the differentiation of tonsillar IL-22-producing IL-1R1(hi) human ILC3s to CD56(bright)CD94(+) interferon (IFN)-γ-producing cytolytic mature NK cells expressing eomesodermin (EOMES) and T-Box Protein 21 (TBX21 or TBET). Hence, we demonstrate the lineage plasticity of human ILCs by identifying AHR as a transcription factor that prevents IL-1R1(hi) ILC3s from differentiating into NK cells.


2 December 2022 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
JFJeffry Florian
Jeffry Florian
QSQin Sun
Qin Sun
SSSarah J. Schrieber
Sarah J. Schrieber
RWRichard White
Richard White
SSSophie Shubow
Sophie Shubow
DSDavid G. Strauss
David G. Strauss

30 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DMDevesh Mishra
Devesh Mishra
NHNicholas R. Harrison
Nicholas R. Harrison
CGCarolina B. Gonzales
Carolina B. Gonzales
BSBjörn Schilström
Björn Schilström
ÅKÅsa Konradsson-Geuken
Åsa Konradsson-Geuken
Ethanol abuse during adolescence may significantly alter development of the prefrontal cortex which continues to undergo structural remodeling into adulthood. Glutamatergic neurotransmission plays an important role during these brain maturation processes and is modulated by ethanol. In this study, we investigated glutamate dynamics in the medial prefrontal cortex of freely moving rats, using enzyme-based microelectrode amperometry. We analyzed the effects of an intraperitoneal ethanol injection (1 g/kg) on cortical glutamate levels in adolescent and adult rats. Notably, basal glutamate levels decreased with age and these levels were found to be significantly different between postnatal day (PND) 28-38 vs PND 44-55 (p<0.05) and PND 28-38 vs adult animals (p<0.001). We also observed spontaneous glutamate release (transients) throughout the recordings. The frequency of transients (per hour) was significantly higher in adolescent rats (PND 28-38 and PND 44-55) compared to those of adults. In adolescent rats, post-ethanol injection, the frequency of glutamate transients decreased within the first hour (p<0.05), it recovered slowly and in the third hour there was a significant rebound increase of the frequency (p<0.05). Our data demonstrate age-dependent differences in extracellular glutamate levels in the medial prefrontal cortex and suggest that acute ethanol injections have both inhibitory and excitatory effects in adolescent rats. These effects of ethanol on the prefrontal cortex may disturb its maturation and possibly limiting individuals´ control over addictive behaviors.

4 June 2020 in Therapeutic Innovation & Regulatory Science
Verified
Journal Article
Closed access
PDF file
NHNicholas R. Harrison
Nicholas R. Harrison
PSPhilip T. Sager
Philip T. Sager
MKMitchell W. Krucoff
Mitchell W. Krucoff
MWMichael A. Weber
Michael A. Weber
WWWilliam B. White
William B. White

5 March 2014 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
DMD. Mishra
D. Mishra
NHN.R. Harrison
N.R. Harrison
CGC.B. Gonzales
C.B. Gonzales
BSB. Schilström
B. Schilström
AKA. Konradsson-Geuken
A. Konradsson-Geuken